![](/img/cover-not-exists.png)
Canakinumab to reduce deterioration of cardiac and respiratory function in SARSâCoVâ2 associated myocardial injury with heightened inflammation (canakinumab in Covidâ19 cardiac injury: The three C study)
Sheng, Calvin C, Sahoo, Debasis, Dugar, Siddharth, Prada, Robier Aguillon, Wang, Tom Kai Ming, Abou Hassan, Ossama K, Brennan, Danielle, Culver, Daniel A, Rajendram, Prabalini, Duggal, Abhijit, LincofJournal:
Clinical Cardiology
DOI:
10.1002/clc.23451
Date:
August, 2020
File:
PDF, 1.57 MB
2020